Article
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
30 Apr 2019
Abstract excerpt
BACKGROUND: Although mutated HLA ligands are considered ideal cancer-specific immunotherapy targets, evidence for their presentation is lacking in hepatocellular carcinomas (HCCs). Employing a unique multi-omics approach comprising a neoepitope identification pipeline, we assessed exome-derived mutations naturally presented as HLA class I ligands in HCCs. METHODS: In-depth multi-omics analyses included whole...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
